Cargando…

Effects of MP-AzeFlu enhanced by activation of bitter taste receptor TAS2R

MP-AzeFlu is relatively new a pharmaceutical drug used in the treatment of allergic rhinitis. It is comprised of azelastine hydrochloride (AZE), a potent histamine-H1-receptor antagonist and fluticasone propionate (FP), corticosteroid. It’s somewhat bitter taste (often considered a disadvantage) can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ekstedt, Sandra, Kumlien Georén, Susanna, Cardell, Lars Olaf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268313/ https://www.ncbi.nlm.nih.gov/pubmed/32514276 http://dx.doi.org/10.1186/s13223-020-00438-w

Ejemplares similares

The effect of MP29-02* is mediated via bitter taste receptors (TAS2R)
por: Ekstedt, Sandra, et al.
Publicado: (2015)

MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis
por: van Weissenbruch, Ranny, et al.
Publicado: (2020)

MP‐AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children
por: Berger, W., et al.
Publicado: (2016)

Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers
por: Roca-Ferrer, Jordi, et al.
Publicado: (2018)

Real‐life effectiveness of MP‐AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy
por: Kaulsay, Ranbir, et al.
Publicado: (2018)

Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma
por: Price, David, et al.
Publicado: (2020)

Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care
por: De Jong, Hilda J.I., et al.
Publicado: (2020)

Real-Life Effectiveness of MP-AzeFlu (Dymista(®)) in Swedish Patients with Persistent Allergic Rhinitis, Assessed by the Visual Analogue Scale
por: Stjärne, Pär, et al.
Publicado: (2023)

A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu
por: Dollner, Ralph, et al.
Publicado: (2017)

Effect of MP‐AzeFlu compared to monotherapy on COX‐2, PGE(2), and EP2 gene expression in upper airway mucosa
por: Vicens‐Artes, Sonia, et al.
Publicado: (2022)

Evaluation of in vitro Penetration of Fluticasone Propionate from MP-AzeFlu and Fluticasone Propionate Nasal Spray Through EpiAirway™606 Tissues Using Vertical Diffusion Cells
por: Berger, William E, et al.
Publicado: (2020)

Superior effect of MP‐AzeFlu compared to monotherapy with fluticasone propionate or azelastine on GILZ, MKP‐1 and TTP anti‐inflammatory gene expression in healthy and inflamed upper airway mucosa
por: Vicens‐Artés, Sònia, et al.
Publicado: (2022)

A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US
por: Prenner, Bruce M
Publicado: (2016)

A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis
por: Zhou, Bing, et al.
Publicado: (2023)

The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers
por: Qi, Wenyuan, et al.
Publicado: (2023)

A possible role for neutrophils in allergic rhinitis revealed after cellular subclassification
por: Arebro, Julia, et al.
Publicado: (2017)

A prolonged innate systemic immune response in COVID-19
por: Ekstedt, Sandra, et al.
Publicado: (2022)

Vanillin Activates Human Bitter Taste Receptors TAS2R14, TAS2R20, and TAS2R39
por: Morini, Gabriella, et al.
Publicado: (2021)

TAS2R38 bitter taste receptor and attainment of exceptional longevity
por: Melis, Melania, et al.
Publicado: (2019)

Probenecid Inhibits the Human Bitter Taste Receptor TAS2R16 and Suppresses Bitter Perception of Salicin
por: Greene, Tiffani A., et al.
Publicado: (2011)

6-Methoxyflavanones as Bitter Taste Receptor Blockers for hTAS2R39
por: Roland, Wibke S. U., et al.
Publicado: (2014)

Genetic Variation in the TAS2R38 Bitter Taste Receptor and Smoking Behaviors
por: Risso, Davide S., et al.
Publicado: (2016)

Global population genetics and diversity in the TAS2R bitter taste receptor family
por: Wooding, Stephen P., et al.
Publicado: (2022)

Increased IL-26 associates with markers of hyperinflammation and tissue damage in patients with acute COVID-19
por: Cardenas, Eduardo I., et al.
Publicado: (2022)

TAS2R38 taste receptor gene and chronic rhinosinusitis: a bitter ending
por: Montrasio, Giulia, et al.
Publicado: (2015)

Rare haplotypes of the gene TAS2R38 confer bitter taste sensitivity in humans
por: Boxer, Emma E., et al.
Publicado: (2015)

TAS2R38 bitter taste genotype is associated with complementary feeding behavior in infants
por: Cont, Gabriele, et al.
Publicado: (2019)

Bitter taste receptor (TAS2R) 46 in human skeletal muscle: expression and activity
por: Talmon, Maria, et al.
Publicado: (2023)

Variation in ligand responses of the bitter taste receptors TAS2R1 and TAS2R4 among New World monkeys
por: Tsutsui, Kei, et al.
Publicado: (2016)

Impact of sweet, umami, and bitter taste receptor (TAS1R and TAS2R) genomic and expression alterations in solid tumors on survival
por: Carey, Ryan M., et al.
Publicado: (2022)

Bitter Taste Receptors (TAS2Rs) in Human Lung Macrophages: Receptor Expression and Inhibitory Effects of TAS2R Agonists
por: Grassin-Delyle, Stanislas, et al.
Publicado: (2019)

A Subset of Mouse Colonic Goblet Cells Expresses the Bitter Taste Receptor Tas2r131
por: Prandi, Simone, et al.
Publicado: (2013)

Deprived TLR9 Expression in Apparently Healthy Nasal Mucosa Might Trigger Polyp-Growth in Chronic Rhinosinusitis Patients
por: Tengroth, Lotta, et al.
Publicado: (2014)

Downregulation of epithelial MHC II expression in chronic rhinosinusitis with polyps
por: Arebro, Julia, et al.
Publicado: (2013)

Antigen presenting epithelial cells play a pivotal role in airway allergy
por: Arebro, Julia, et al.
Publicado: (2015)

A role for neuropeptides in innate immune inflammation of the nose
por: Larsson, Olivia, et al.
Publicado: (2015)

The SP‐TLR axis, which locally primes the nasal mucosa, is impeded in patients with allergic rhinitis
por: Larsson, Olivia, et al.
Publicado: (2021)

Upregulated expression of Notch1/4 - JAG-1/DLL-1 detected in allergic rhinitis
por: Hjalmarsson, Eric, et al.
Publicado: (2023)

Genetic Variation in the TAS2R38 Bitter Taste Receptor and Gastric Cancer Risk in Koreans
por: Choi, Jeong-Hwa, et al.
Publicado: (2016)

Lipopolysaccharide increases bitter taste sensitivity via epigenetic changes in Tas2r gene clusters
por: Lin, Cailu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d75d0ddgru2li8malifrdmtb7n